Radiopharmaceuticals

Radiopharm Fundamentals - Tiny Tracer Tactics

• Definition: Radioactive drug = Radionuclide (emits γ-rays) + Pharmaceutical (targets tissue).
• Components:
  • Radionuclide: e.g., $^{99m}Tc$, $^{131}I$, $^{18}F$. Provides signal.
  • Pharmaceutical: Carrier; dictates biodistribution.
• Ideal Radionuclide:
  • $T_p$: Short (e.g., $^{99m}Tc$: 6 hrs).
  • Emission: Pure γ-rays (100-200 keV). No α/β for imaging.
  • Source: Generator (e.g., $^{99m}Tc$), readily available.
  • High specific activity.
• Ideal Radiopharmaceutical:
  • Safe: Non-toxic.
  • Stable: In vitro & in vivo.
  • Kinetics: High target uptake, rapid background clearance.
  • $T_{eff}$: Optimal; $T_{eff} = (T_p \times T_b) / (T_p + T_b)$ ($T_b$: biological half-life).

⭐ Most common: Technetium-99m ($^{99m}Tc$) - near-ideal 140 keV gamma energy, 6-hour physical half-life, generator-produced.

Radionuclide Production - Isotope Forge

• Nuclear Reactor:
  • Method: Neutron bombardment (e.g., $(n, \gamma)$ reaction, fission).
  • Products: Neutron-rich isotopes (e.g., $^{99}Mo$, $^{131}I$). Carrier-added or carrier-free.
  • Example reaction: $^{98}Mo(n, \gamma)^{99}Mo$.
• Cyclotron:
  • Method: Charged particle bombardment (e.g., protons, deuterons).
  • Products: Proton-rich (neutron-deficient) isotopes. Often carrier-free, high specific activity.
  • 📌 CUTE PET: $^{11}C, ^{13}N, ^{15}O, ^{18}F$.
  • Others: $^{67}Ga, ^{111}In, ^{201}Tl, ^{123}I$.
• Radionuclide Generator:
  • Principle: Long-lived parent isotope (e.g., $^{99}Mo$ from reactor) decays to a short-lived daughter isotope ($^{99m}Tc$).
  • Advantage: On-site, convenient source of short-lived radionuclides.
  • Key System: $^{99}Mo$ (half-life 66 hrs) $\rightarrow$ $^{99m}Tc$ (half-life 6 hrs) $+ \beta^- + \bar{\nu}_e$.

⭐ The $^{99}Mo$/$^{99m}Tc$ generator operates on the principle of transient equilibrium.

Key Radiopharm Agents - Scan Superstars

• Technetium-99m (Tc-99m) Based Agents: Most common due to ideal energy (140 keV) & 6-hr half-life.

  Agent	Pharmaceutical	Primary Use(s)
  Tc-99m MDP	Methylene Diphosphonate	Bone scans (mets, fractures, osteomyelitis)
  Tc-99m MAA	Macroaggregated Albumin	Lung perfusion (PE diagnosis)
  Tc-99m MIBI	Sestamibi	Myocardial perfusion, Parathyroid adenoma
  Tc-99m DTPA	Diethylenetriaminepentaacetic acid	Renal (GFR, perfusion), Brain SPECT, Aerosol V/Q
  Tc-99m SC	Sulphur Colloid	Liver/spleen, Lymphoscintigraphy, Gastric empty
  Tc-99m $TcO_4^-$	Pertechnetate	Thyroid, Meckel's, Salivary glands
  Tc-99m HMPAO	Exametazime	Cerebral blood flow SPECT, Infection imaging
  📌 Mnemonic: MDP for Bone, MAA for Lungs, MIBI for Heart & Parathyroid.

• Other Key Agents:

  • I-131 Sodium Iodide: Thyroid uptake & therapy (hyperthyroidism, Ca). Therapy dose 5-200 mCi.
  • F-18 FDG (Fluorodeoxyglucose): PET (oncology, cardiology, neurology). Adult dose 5-10 mCi.
  • Ga-67 Citrate: Tumor (lymphoma) & inflammation (sarcoidosis, FUO).
  • Ga-68 DOTATATE/NOC/TOC: PET/CT for Neuroendocrine Tumors (NETs) - somatostatin receptors.
  • Tl-201 Thallous Chloride: Myocardial perfusion, parathyroid. K+ analog.
  • In-111 Octreotide: SPECT for NETs (somatostatin receptors).

⭐ F-18 FDG accumulates in metabolically active tissues (tumors, brain, myocardium) via GLUT transporters, similar to glucose.

QC & Safety - Pure & Prudent Probes

• Quality Control (QC) Tests: Key checks for radiopharmaceutical integrity.

⭐ Radiochemical purity testing (e.g., by TLC) is crucial to ensure the radionuclide is bound to the correct pharmaceutical, impacting diagnostic accuracy and patient safety.

• Radiation Safety:
  • 📌 ALARA: As Low As Reasonably Achievable.
  • Principles: Minimize Time, Maximize Distance, Use Shielding.
  • Monitoring: Personnel (dosimeters), Area (surveys).

High‑Yield Points - ⚡ Biggest Takeaways

• Technetium-99m (Tc-99m): Most common radiopharmaceutical, 6-hour half-life, emits 140 keV gamma rays, used for versatile imaging.
• Iodine-131 (I-131): Used for thyroid imaging and therapy (e.g., Graves', thyroid cancer); emits both beta & gamma radiation.
• FDG (F-18): Key PET radiotracer for oncology (cancer staging), myocardial viability, and brain imaging.
• Gallium-67 Citrate: Accumulates in tumors (especially lymphoma) and sites of inflammation or infection.
• Thallium-201: Employed for myocardial perfusion imaging; behaves as a potassium (K+) analog.
• Mo-99/Tc-99m generator: Crucial for on-site, on-demand Tc-99m production in nuclear medicine departments.
• Ideal radiopharmaceuticals have a short effective half-life, emit pure gamma rays, and ensure low patient radiation dose.